Kayela Arrotta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Kayela Arrotta has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Robyn M. Busch
Epilepsy Center Neurological Institute, Cleveland Clinic Cleveland Ohio USA
15 shared publications - Bruce P. Hermann
Department of Neurology University of Wisconsin School of Medicine and Public Health Madison Wisconsin USA
11 shared publications - Anny Reyes
Epilepsy Center and Neurological Institute, Cleveland Clinic
10 shared publications - Lisa Ferguson
Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
8 shared publications - Carrie R. McDonald
Departments of Psychiatry and Radiation Medicine and Applied Sciences University of California‐San Diego San Diego California USA
7 shared publications - Julie K. Janecek
Department of Neurology, Medical College of Wisconsin, Milwaukee, WI, USA
5 shared publications
Latest Publications
- Open Access
- 22 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186, 111346
Assessing cognitive compensatory strategy use in epilepsy: Pilot validation of the everyday compensation questionnaire
- 22 October 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 186, 111346
Open AccessAssessing cognitive compensatory strategy use in epilepsy: Pilot validation of the everyday compensation questionnaire
- Open Access
- 25 September 2026
- Published by Wiley in Epilepsia Open
Prepare, don't scare: Rethinking cognitive readiness before epilepsy surgery
Epilepsy surgery is an effective but underutilized treatment for drug‐resistant epilepsy, and concerns about postsurgical cognitive change are a prominent barrier. Refinements in surgical technique can reduce cognitive impact, but cognitive change cannot always be avoided, and approaches carrying lower cognitive risk are often less effective for seizure control. Cognitive change therefore needs to be addressed directly rather than minimized through surgical strategy alone. This article proposes cognitive prehabilitation, a structured presurgical intervention combining individualized risk–benefit education, compensatory strategy training, and recovery planning, as a potential advancement in presurgical care. A central conceptual shift is reframing potential postsurgical cognitive decline from an outcome to be feared to a cost that patients can prepare for, adapt to, and weigh against the benefits of seizure freedom. The literature specific to cognitive prehabilitation in epilepsy surgery is too limited to support systematic review; thus, we draw on adjacent evidence bases, including cognitive rehabilitation in epilepsy, prehabilitation in other surgical populations, and literatures on shared decision‐making and risk communication, to outline complementary frameworks. We detail theoretical components of cognitive prehabilitation, including risk communication and expectation setting, cognitive compensatory training, attention to mental and physical wellbeing, planning for postsurgical recovery, and peer support. Clinical and structural barriers to implementation are discussed, including patient engagement challenges and healthcare constraints. Priorities for future research include standardization of prehabilitation protocols, identification of patient‐level moderators of benefit, and scalable delivery formats. Cognitive prehabilitation represents an opportunity to move toward empowerment‐based presurgical care and to expand access to epilepsy surgery. Plain Language Summary: Many people with drug‐resistant epilepsy avoid surgery because of the risks associated with declines in memory and thinking. This article describes the concept of cognitive prehabilitation, which is a presurgical program that gives patients personalized information about what may change with surgery, teaches practical strategies for managing memory and thinking difficulties should they arise, and helps them plan for recovery. The aim is for patients to prepare for possible memory and thinking changes rather than simply fear them. Research is still early, and studies are needed to test whether prehabilitation improves outcomes.
- 25 September 2026
- Published by Wiley in Epilepsia Open
Open AccessPrepare, don't scare: Rethinking cognitive readiness before epilepsy surgery
Epilepsy surgery is an effective but underutilized treatment for drug‐resistant epilepsy, and concerns about postsurgical cognitive change are a prominent barrier. Refinements in surgical technique can reduce cognitive impact, but cognitive change cannot always be avoided, and approaches carrying lower cognitive risk are often less effective for seizure control. Cognitive change therefore needs to be addressed directly rather than minimized through surgical strategy alone. This article proposes cognitive prehabilitation, a structured presurgical intervention combining individualized risk–benefit education, compensatory strategy training, and recovery planning, as a potential advancement in presurgical care. A central conceptual shift is reframing potential postsurgical cognitive decline from an outcome to be feared to a cost that patients can prepare for, adapt to, and weigh against the benefits of seizure freedom. The literature specific to cognitive prehabilitation in epilepsy surgery is too limited to support systematic review; thus, we draw on adjacent evidence bases, including cognitive rehabilitation in epilepsy, prehabilitation in other surgical populations, and literatures on shared decision‐making and risk communication, to outline complementary frameworks. We detail theoretical components of cognitive prehabilitation, including risk communication and expectation setting, cognitive compensatory training, attention to mental and physical wellbeing, planning for postsurgical recovery, and peer support. Clinical and structural barriers to implementation are discussed, including patient engagement challenges and healthcare constraints. Priorities for future research include standardization of prehabilitation protocols, identification of patient‐level moderators of benefit, and scalable delivery formats. Cognitive prehabilitation represents an opportunity to move toward empowerment‐based presurgical care and to expand access to epilepsy surgery. Plain Language Summary: Many people with drug‐resistant epilepsy avoid surgery because of the risks associated with declines in memory and thinking. This article describes the concept of cognitive prehabilitation, which is a presurgical program that gives patients personalized information about what may change with surgery, teaches practical strategies for managing memory and thinking difficulties should they arise, and helps them plan for recovery. The aim is for patients to prepare for possible memory and thinking changes rather than simply fear them. Research is still early, and studies are needed to test whether prehabilitation improves outcomes.
- 21 September 2026
- Published by Wiley in Epileptic Disorders
Diagnostic accuracy of the ADAS ‐Cog‐13 as a cognitive screening tool in older adults with focal epilepsy: A multicenter cross‐sectional study
Objective: Cognitive impairment is common among older adults with epilepsy, and although the Montreal Cognitive Assessment (MoCA) has demonstrated validity as a screening tool in this population, additional efficient screening options are needed. Here we examine, for the first time, the diagnostic accuracy of the Alzheimer's Disease Assessment Scale‐Cognitive‐13 Item Subscale (ADAS‐Cog‐13) as a screening tool to identify cognitive impairment in older adults with focal epilepsy. Methods: Participants included 83 adults (ages ≥55) with focal epilepsy from the Brain, Aging, and Cognition in Epilepsy (BrACE) study and 83 age‐, sex‐, and education‐matched cognitively healthy controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI‐3). All completed the ADAS‐Cog‐13 and a comprehensive neuropsychological battery that was analyzed through the International Cognitive Disorders in Epilepsy (IC‐CoDE) system to identify cognitive phenotypes (intact vs. impaired). Performance on the individual ADAS‐Cog‐13 total score and items was assessed, clinical and sociodemographic features characterized, and diagnostic efficiency statistics determined and compared with MoCA performance. Results: Focal epilepsy participants (mean age = 66.4 years) performed significantly worse across the ADAS‐Cog‐13 total score and 8 of the 13 individual test items compared with controls. The largest effect sizes were observed on verbal learning and memory tasks, particularly word recall ( d = .87) and delayed word recall ( d = 1.06). An ADAS‐Cog‐13 total score of ≥15 yielded optimal diagnostic efficiency (67.5% accuracy, 68.8% sensitivity, 66.7% specificity) for identifying cognitive impairment—similar to MoCA performance. Significance: The ADAS‐Cog‐13 is sensitive to detecting cognitive impairment in older adults with focal epilepsy and may represent a scalable screening option in this population. Additional comparative studies in older epilepsy populations are needed to determine the sensitivity of this measure to longitudinal change, cross‐cultural applicability, and availability across languages. Plain Language Summary: Cognitive decline is common among older adults with epilepsy. Although the Montreal Cognitive Assessment (MoCA) has been shown to be a valid screening tool in this population, additional options are needed. The ADAS‐Cog‐13 may be a useful screening option in epilepsy research and clinical care, although additional studies are needed to compare it with other cognitive screening tests and to confirm its applicability for clinical care and across healthcare settings and cultures.
- 21 September 2026
- Published by Wiley in Epileptic Disorders
Diagnostic accuracy of the ADAS ‐Cog‐13 as a cognitive screening tool in older adults with focal epilepsy: A multicenter cross‐sectional study
Objective: Cognitive impairment is common among older adults with epilepsy, and although the Montreal Cognitive Assessment (MoCA) has demonstrated validity as a screening tool in this population, additional efficient screening options are needed. Here we examine, for the first time, the diagnostic accuracy of the Alzheimer's Disease Assessment Scale‐Cognitive‐13 Item Subscale (ADAS‐Cog‐13) as a screening tool to identify cognitive impairment in older adults with focal epilepsy. Methods: Participants included 83 adults (ages ≥55) with focal epilepsy from the Brain, Aging, and Cognition in Epilepsy (BrACE) study and 83 age‐, sex‐, and education‐matched cognitively healthy controls from the Alzheimer's Disease Neuroimaging Initiative (ADNI‐3). All completed the ADAS‐Cog‐13 and a comprehensive neuropsychological battery that was analyzed through the International Cognitive Disorders in Epilepsy (IC‐CoDE) system to identify cognitive phenotypes (intact vs. impaired). Performance on the individual ADAS‐Cog‐13 total score and items was assessed, clinical and sociodemographic features characterized, and diagnostic efficiency statistics determined and compared with MoCA performance. Results: Focal epilepsy participants (mean age = 66.4 years) performed significantly worse across the ADAS‐Cog‐13 total score and 8 of the 13 individual test items compared with controls. The largest effect sizes were observed on verbal learning and memory tasks, particularly word recall ( d = .87) and delayed word recall ( d = 1.06). An ADAS‐Cog‐13 total score of ≥15 yielded optimal diagnostic efficiency (67.5% accuracy, 68.8% sensitivity, 66.7% specificity) for identifying cognitive impairment—similar to MoCA performance. Significance: The ADAS‐Cog‐13 is sensitive to detecting cognitive impairment in older adults with focal epilepsy and may represent a scalable screening option in this population. Additional comparative studies in older epilepsy populations are needed to determine the sensitivity of this measure to longitudinal change, cross‐cultural applicability, and availability across languages. Plain Language Summary: Cognitive decline is common among older adults with epilepsy. Although the Montreal Cognitive Assessment (MoCA) has been shown to be a valid screening tool in this population, additional options are needed. The ADAS‐Cog‐13 may be a useful screening option in epilepsy research and clinical care, although additional studies are needed to compare it with other cognitive screening tests and to confirm its applicability for clinical care and across healthcare settings and cultures.
- Open Access
Utility of the ADAS-Cog as a Cognitive Screening Tool in Older Adults with Epilepsy: A Multicenter Cohort Study
Objective: Cognitive impairment is common among older adults with epilepsy, although efficient screening tools suitable for routine use are lacking. Here we examine, for the first time, the utility of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) as a screening tool to identify cognitive impairment in older adults with epilepsy. Methods: Participants included 83 adults (ages ≥ 55) with epilepsy from the Brain, Aging, and Cognition in Epilepsy (BrACE) study and 83 age-, sex-, and education-matched cognitively healthy controls from the Alzheimer’s Disease Neuroimaging Initiative (ADNI-3). All completed the ADAS-Cog and a comprehensive neuropsychological battery to identify cognitive phenotypes (intact vs impaired). Performance on individual ADAS-Cog items and the total score was assessed, and diagnostic efficiency statistics were determined. Results: Epilepsy participants (mean age=66.4 years) performed significantly worse across the ADAS-Cog total score and 8 of the 13 individual test items compared to controls. The largest effect sizes were observed on verbal learning and memory tasks, particularly word recall ( d =0.87) and delayed word recall ( d =1.06). An ADAS-Cog total score of ≥15 yielded optimal diagnostic efficiency (67.5% accuracy, 68.8% sensitivity, 66.7% specificity) for identifying cognitive impairment. Significance: The ADAS-Cog is sensitive to detecting cognitive impairment in older adults with epilepsy and may represent a scalable screening option in this population. Additional comparative studies in older epilepsy populations are needed to determine the sensitivity of this measure to longitudinal change, cross-cultural applicability, and availability across languages. Plain language summary: Cognitive decline is common among older adults with epilepsy, although sufficient evidence supporting the use of screening tools to identify cognitive impairment in this population is lacking. The ADAS-Cog may be a useful screening option in epilepsy research and clinical care, although additional studies are needed to compare it with other cognitive screening tests and to confirm its applicability for clinical care and across cultures and healthcare settings. Key Points: □ ADAS-Cog, a tool widely used in Alzheimer’s disease research, was used to detect cognitive impairment in older adults with epilepsy versus healthy controls. □ Largest deficits were in verbal learning and delayed recall, aligning with epilepsy-related memory vulnerability. □ ADAS-Cog was compared with the gold standard, the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE). An ADAS-Cog-13 cutoff ≥15 showed optimal accuracy for IC-CoDE–defined cognitive impairment. □ ADAS-Cog performance reliably distinguished IC-CoDE-impaired from intact participants within the epilepsy cohort. □ These findings support ADAS-Cog as a cognitive screening tool in aging epilepsy populations to identify neurodegenerative vulnerability.
Open AccessUtility of the ADAS-Cog as a Cognitive Screening Tool in Older Adults with Epilepsy: A Multicenter Cohort Study
Objective: Cognitive impairment is common among older adults with epilepsy, although efficient screening tools suitable for routine use are lacking. Here we examine, for the first time, the utility of the Alzheimer’s Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) as a screening tool to identify cognitive impairment in older adults with epilepsy. Methods: Participants included 83 adults (ages ≥ 55) with epilepsy from the Brain, Aging, and Cognition in Epilepsy (BrACE) study and 83 age-, sex-, and education-matched cognitively healthy controls from the Alzheimer’s Disease Neuroimaging Initiative (ADNI-3). All completed the ADAS-Cog and a comprehensive neuropsychological battery to identify cognitive phenotypes (intact vs impaired). Performance on individual ADAS-Cog items and the total score was assessed, and diagnostic efficiency statistics were determined. Results: Epilepsy participants (mean age=66.4 years) performed significantly worse across the ADAS-Cog total score and 8 of the 13 individual test items compared to controls. The largest effect sizes were observed on verbal learning and memory tasks, particularly word recall ( d =0.87) and delayed word recall ( d =1.06). An ADAS-Cog total score of ≥15 yielded optimal diagnostic efficiency (67.5% accuracy, 68.8% sensitivity, 66.7% specificity) for identifying cognitive impairment. Significance: The ADAS-Cog is sensitive to detecting cognitive impairment in older adults with epilepsy and may represent a scalable screening option in this population. Additional comparative studies in older epilepsy populations are needed to determine the sensitivity of this measure to longitudinal change, cross-cultural applicability, and availability across languages. Plain language summary: Cognitive decline is common among older adults with epilepsy, although sufficient evidence supporting the use of screening tools to identify cognitive impairment in this population is lacking. The ADAS-Cog may be a useful screening option in epilepsy research and clinical care, although additional studies are needed to compare it with other cognitive screening tests and to confirm its applicability for clinical care and across cultures and healthcare settings. Key Points: □ ADAS-Cog, a tool widely used in Alzheimer’s disease research, was used to detect cognitive impairment in older adults with epilepsy versus healthy controls. □ Largest deficits were in verbal learning and delayed recall, aligning with epilepsy-related memory vulnerability. □ ADAS-Cog was compared with the gold standard, the International Classification of Cognitive Disorders in Epilepsy (IC-CoDE). An ADAS-Cog-13 cutoff ≥15 showed optimal accuracy for IC-CoDE–defined cognitive impairment. □ ADAS-Cog performance reliably distinguished IC-CoDE-impaired from intact participants within the epilepsy cohort. □ These findings support ADAS-Cog as a cognitive screening tool in aging epilepsy populations to identify neurodegenerative vulnerability.
- Open Access
- 28 May 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 182, 111137
Comparing normative and ipsative methods of IC-CoDE phenotype classification in frontal lobe epilepsy
- 28 May 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 182, 111137
Open AccessComparing normative and ipsative methods of IC-CoDE phenotype classification in frontal lobe epilepsy
- Open Access
The International Classification of Cognitive Disorders in Epilepsy ( IC ‐ CoDE ) Portal: An open source resource for neuropsychological research in epilepsy
Objective: The International Classification of Cognitive Disorders in Epilepsy (IC‐CoDE) is a consensus‐based, empirically‐driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC‐CoDE phenotypes in group data is laborious and time‐consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC‐CoDE phenotypes to further multicenter epilepsy research. Methods: To remove this barrier, we developed the IC‐CoDE Portal ( https://ic‐code‐portal.ccf.org/ ), an interactive and user‐friendly, web‐based platform to support the scientific community in performing IC‐CoDE individual level classification through web interface or bulk classification through uploading of data files. The Portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC‐CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC‐CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi‐center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC‐CoDE Portal will springboard large‐scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
Open AccessThe International Classification of Cognitive Disorders in Epilepsy ( IC ‐ CoDE ) Portal: An open source resource for neuropsychological research in epilepsy
Objective: The International Classification of Cognitive Disorders in Epilepsy (IC‐CoDE) is a consensus‐based, empirically‐driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC‐CoDE phenotypes in group data is laborious and time‐consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC‐CoDE phenotypes to further multicenter epilepsy research. Methods: To remove this barrier, we developed the IC‐CoDE Portal ( https://ic‐code‐portal.ccf.org/ ), an interactive and user‐friendly, web‐based platform to support the scientific community in performing IC‐CoDE individual level classification through web interface or bulk classification through uploading of data files. The Portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC‐CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC‐CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi‐center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC‐CoDE Portal will springboard large‐scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
- 16 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110938
Defining cognitive impairment in temporal lobe epilepsy with IC-CoDE phenotypes: A comparison of normative and ipsative approaches
- 16 February 2026
- Published by Elsevier in Epilepsy & Behavior
- Vol. 177, 110938
Defining cognitive impairment in temporal lobe epilepsy with IC-CoDE phenotypes: A comparison of normative and ipsative approaches
- Open Access
The International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) Portal: An Open Source Resource for Neuropsychological Research in Epilepsy
Background: The International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) is a consensus-based, empirically-driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC-CoDE phenotypes in group data is laborious and time-consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC-CoDE phenotypes to further multicenter epilepsy research. Methods/Results: To remove this barrier, we developed the IC-CoDE portal ( https://ic-code-portal.ccf.org/ ), an interactive and user-friendly, web-based platform to support the scientific community in performing IC-CoDE individual level classification through web interface or bulk classification through upload of data files. The portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC-CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC-CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi-center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC-CoDE portal will springboard large-scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
Open AccessThe International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) Portal: An Open Source Resource for Neuropsychological Research in Epilepsy
Background: The International Classification of Cognitive Disorders in Epilepsy (IC-CoDE) is a consensus-based, empirically-driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC-CoDE phenotypes in group data is laborious and time-consuming, particularly in datasets containing heterogenous cognitive measures or batteries, limiting the widespread adoption of IC-CoDE phenotypes to further multicenter epilepsy research. Methods/Results: To remove this barrier, we developed the IC-CoDE portal ( https://ic-code-portal.ccf.org/ ), an interactive and user-friendly, web-based platform to support the scientific community in performing IC-CoDE individual level classification through web interface or bulk classification through upload of data files. The portal also allows the user to generate and visualize cohort summary statistics of cognitive phenotypes in their dataset, with the option of filtering the data interactively by specified demographic or clinical variables of interest. We further made the resulting IC-CoDE phenotypes downloadable as a spreadsheet to foster offline analysis of cognitive data by members of the epilepsy research community. Significance: Ascertainment of cognitive profiles is key to understanding the natural heterogeneity in the clinical presentation of the epilepsies and their comorbidities. The IC-CoDE taxonomy can be applied to any comprehensive neuropsychological battery, regardless of the specific test measures and normative data used or the language and culture in which the assessment took place, making it an ideal tool to accelerate international multi-center studies on cognition in epilepsy. We hope that by eliminating some of the barriers associated with cognitive phenotyping, the IC-CoDE portal will springboard large-scale collaborative efforts to further our understanding of the neuropsychology of the epilepsies.
- Open Access
Readiness Brain Operation Optimization Training (ReBOOT) protocol: a feasibility randomised controlled trial for a cognitive prehabilitation programme for epilepsy surgery conducted at Cleveland Clinic, USA
Introduction: Risk of cognitive decline following epilepsy surgery can be a significant barrier for patients pursuing surgery, and post-surgical cognitive changes can impact quality of life (QOL), surgical satisfaction and functional independence. Readiness Brain Operation Optimization Training (ReBOOT) is a virtual cognitive prehabilitation intervention that provides patients with psychoeducation and cognitive strategies prior to surgery to increase pre-surgical preparedness and post-surgical functional independence in the circumstance that a patient experiences cognitive decline after surgery. The primary aim of this feasibility trial is to evaluate the acceptability, adherence and procedural feasibility of implementing ReBOOT in patients being evaluated for epilepsy surgery. Secondary, explorative objectives include examining preliminary trends in QOL, compensatory strategy use, cognitive function and psychosocial outcomes to inform a future definitive trial. Methods and analysis: This is a single-centre, parallel-group, feasibility randomised controlled trial of a standardised cognitive prehabilitation programme for patients who are considering epilepsy surgery. Participants are randomly assigned to intervention (n=32) or control groups (n=32). The intervention group is enrolled in ReBOOT, a virtual programme that includes two 1-hour individual sessions and four 1-hour group sessions. Feasibility outcomes include attendance, homework adherence, attrition and participant satisfaction for participants randomised to the intervention group. Exploratory analyses will use longitudinal linear mixed-effects models to describe trends in exploratory outcomes over time. Data will be used to refine procedures and estimate parameters (eg, effect sizes and variance) for a future fully powered trial. Ethics and dissemination: Cleveland Clinic Institutional Review Board approved the study protocol, which is publicly available and registered on the National Institutes of Health ClinicalTrials.gov ( NCT05992402 ) site. Results will be disseminated through conference presentations and academic publications, as well as shared with outside study sponsors (Society for Clinical Neuropsychology—Division 40 of the American Psychological Association; American Epilepsy Society). Trial registration number: NCT05992402 .
Open AccessReadiness Brain Operation Optimization Training (ReBOOT) protocol: a feasibility randomised controlled trial for a cognitive prehabilitation programme for epilepsy surgery conducted at Cleveland Clinic, USA
Introduction: Risk of cognitive decline following epilepsy surgery can be a significant barrier for patients pursuing surgery, and post-surgical cognitive changes can impact quality of life (QOL), surgical satisfaction and functional independence. Readiness Brain Operation Optimization Training (ReBOOT) is a virtual cognitive prehabilitation intervention that provides patients with psychoeducation and cognitive strategies prior to surgery to increase pre-surgical preparedness and post-surgical functional independence in the circumstance that a patient experiences cognitive decline after surgery. The primary aim of this feasibility trial is to evaluate the acceptability, adherence and procedural feasibility of implementing ReBOOT in patients being evaluated for epilepsy surgery. Secondary, explorative objectives include examining preliminary trends in QOL, compensatory strategy use, cognitive function and psychosocial outcomes to inform a future definitive trial. Methods and analysis: This is a single-centre, parallel-group, feasibility randomised controlled trial of a standardised cognitive prehabilitation programme for patients who are considering epilepsy surgery. Participants are randomly assigned to intervention (n=32) or control groups (n=32). The intervention group is enrolled in ReBOOT, a virtual programme that includes two 1-hour individual sessions and four 1-hour group sessions. Feasibility outcomes include attendance, homework adherence, attrition and participant satisfaction for participants randomised to the intervention group. Exploratory analyses will use longitudinal linear mixed-effects models to describe trends in exploratory outcomes over time. Data will be used to refine procedures and estimate parameters (eg, effect sizes and variance) for a future fully powered trial. Ethics and dissemination: Cleveland Clinic Institutional Review Board approved the study protocol, which is publicly available and registered on the National Institutes of Health ClinicalTrials.gov ( NCT05992402 ) site. Results will be disseminated through conference presentations and academic publications, as well as shared with outside study sponsors (Society for Clinical Neuropsychology—Division 40 of the American Psychological Association; American Epilepsy Society). Trial registration number: NCT05992402 .
- Open Access
Feasibility of and patient satisfaction with Readiness Brain Operation Optimization Training, a manualized cognitive prehabilitation program for epilepsy surgery
Objective: Readiness Brain Operation Optimization Training (ReBOOT) is a manualized cognitive prehabilitation program for patients considering epilepsy surgery designed to improve presurgical preparedness through education and reduce the impact of postsurgical cognitive changes with preemptive cognitive compensatory training. The purpose of this study was to understand the feasibility of cognitive prehabilitation, examine patient satisfaction with ReBOOT, and assess changes in compensatory strategy use following ReBOOT. Methods: Seventeen participants (65% female, mean age = 41 years) considering epilepsy surgery were enrolled in ReBOOT, which includes two one‐on‐one psychoeducation sessions, four group sessions on cognitive compensatory strategies, and weekly goal setting to facilitate implementation of strategies. Patient retention, attendance, and goal completion were tracked. Participants also completed the Everyday Compensation Questionnaire pre‐ and postintervention along with a satisfaction survey postintervention. Aggregate ratings were examined, and paired samples t ‐test was used to assess change in compensatory strategy use postintervention. Results: Five participants withdrew shortly after consent, prior to starting ReBOOT, because of a change in surgical status/date or lack of desire to complete relevant study activities. Of the 12 remaining participants, only two missed one session. Participants indicated that they found ReBOOT to be quite beneficial, reported satisfaction with the information and support provided by ReBOOT, and felt that ReBOOT was effective at preparing them for epilepsy surgery and potential postsurgical cognitive changes. Most participants made some (i.e., little to moderate) progress on their goals each week and demonstrated increased compensatory strategy use by the end of ReBOOT. Significance: Findings indicate that cognitive prehabilitation is feasible. Participants reported high satisfaction with ReBOOT, reporting multiple benefits, and demonstrated increased compensatory strategy use following program completion. These results highlight cognitive prehabilitation for epilepsy surgery as a worthwhile pursuit and demonstrate that ReBOOT may serve as a useful clinical resource in the future following further validation of its efficacy.
Open AccessFeasibility of and patient satisfaction with Readiness Brain Operation Optimization Training, a manualized cognitive prehabilitation program for epilepsy surgery
Objective: Readiness Brain Operation Optimization Training (ReBOOT) is a manualized cognitive prehabilitation program for patients considering epilepsy surgery designed to improve presurgical preparedness through education and reduce the impact of postsurgical cognitive changes with preemptive cognitive compensatory training. The purpose of this study was to understand the feasibility of cognitive prehabilitation, examine patient satisfaction with ReBOOT, and assess changes in compensatory strategy use following ReBOOT. Methods: Seventeen participants (65% female, mean age = 41 years) considering epilepsy surgery were enrolled in ReBOOT, which includes two one‐on‐one psychoeducation sessions, four group sessions on cognitive compensatory strategies, and weekly goal setting to facilitate implementation of strategies. Patient retention, attendance, and goal completion were tracked. Participants also completed the Everyday Compensation Questionnaire pre‐ and postintervention along with a satisfaction survey postintervention. Aggregate ratings were examined, and paired samples t ‐test was used to assess change in compensatory strategy use postintervention. Results: Five participants withdrew shortly after consent, prior to starting ReBOOT, because of a change in surgical status/date or lack of desire to complete relevant study activities. Of the 12 remaining participants, only two missed one session. Participants indicated that they found ReBOOT to be quite beneficial, reported satisfaction with the information and support provided by ReBOOT, and felt that ReBOOT was effective at preparing them for epilepsy surgery and potential postsurgical cognitive changes. Most participants made some (i.e., little to moderate) progress on their goals each week and demonstrated increased compensatory strategy use by the end of ReBOOT. Significance: Findings indicate that cognitive prehabilitation is feasible. Participants reported high satisfaction with ReBOOT, reporting multiple benefits, and demonstrated increased compensatory strategy use following program completion. These results highlight cognitive prehabilitation for epilepsy surgery as a worthwhile pursuit and demonstrate that ReBOOT may serve as a useful clinical resource in the future following further validation of its efficacy.